Premium
An engineered CX3CR1 antagonist endowed with anti‐inflammatory activity
Author(s) -
Dorgham Karim,
Ghadiri Ata,
Hermand Patricia,
Rodero Mathieu,
Poupel Lucie,
Iga Mutsumori,
Hartley Oliver,
Gorochov Guy,
Combadière Christophe,
Deterre Philippe
Publication year - 2009
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0308158
Subject(s) - cx3cl1 , cx3cr1 , chemokine , chemotaxis , biology , microbiology and biotechnology , inflammation , chemokine receptor , in vivo , in vitro , internalization , pharmacology , receptor , immunology , biochemistry
Identification of a chemokine analogue that antagonized CX3CL1‐CX3CR1‐dependent responses both in vitro and in vivo